ANALYSIS OF THE EFFECT OF GALANTAMINE IN THE TREATMENT OF MILD TO MODERATE ALZHEIMER'S DISEASE (AD)

被引：0
作者：
Moruzzi, E. [1 ]
机构：
[1] Voila Hosp, Campina, Romania
来源：
EUROPEAN PSYCHIATRY | 2012年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
P-455
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Switching, strategy with galantamine in the treatment of patients with mild to moderate Alzheimer's disease
    Hwang, T-Y.
    Ahn, I-S.
    Yun, J.
    Kim, S.
    Kim, D. K.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 172 - 172
  • [2] The Prediction of Response to Galantamine Treatment in Patients with Mild to Moderate Alzheimer's Disease
    Ohnishi, Takashi
    Sakiyama, Yojiro
    Okuri, Yuichi
    Kimura, Yuji
    Sugiyama, Nami
    Saito, Takayuki
    Takahashi, Masayoshi
    Kobayashi, Takumi
    CURRENT ALZHEIMER RESEARCH, 2014, 11 (02) : 110 - 118
  • [3] Galantamine-ER for the treatment of mild-to-moderate Alzheimer's disease
    Seltzer, Ben
    CLINICAL INTERVENTIONS IN AGING, 2010, 5 : 1 - 6
  • [4] Economic impact of galantamine in mild to moderate Alzheimer's disease
    Caro, J
    Migliaccio-Walle, K
    Ishak, KJ
    Getsios, D
    O'Brien, JA
    Papadopoulos, G
    ANNALS OF NEUROLOGY, 2001, 50 (03) : S79 - S79
  • [5] Safety and effectiveness of galantamine for mild to moderate Alzheimer's disease
    Alvarez, F. J.
    Blesa, R.
    Ezpeleta, D.
    Romo, I.
    Garcia-Ribas, G.
    EUROPEAN JOURNAL OF NEUROLOGY, 2006, 13 : 73 - 73
  • [6] Economic analysis of galantamine, a cholinesterase inhibitor, in the treatment of patients with mild to moderate Alzheimer's disease in the Netherlands
    Caro, JJ
    Salas, M
    Ward, A
    Getsios, D
    Mehnert, A
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2002, 14 (02) : 84 - 89
  • [7] The safety of combined galantamine-memantine treatment in mild to moderate Alzheimer's disease
    Ramaswamy, K.
    Amatniek, J.
    Crivera, C.
    Rupnow, M.
    Zhu, Y.
    Hammond, G.
    EUROPEAN JOURNAL OF NEUROLOGY, 2006, 13 : 68 - 68
  • [8] Galantamine prolonged-release formulation in the treatment of mild to moderate Alzheimer's disease
    Brodaty, H
    Corey-Bloom, J
    Potocnik, FCV
    Truyen, L
    Gold, M
    Damaraju, CRV
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2005, 20 (2-3) : 120 - 132
  • [9] Safety of galantamine and memantine in combination usage in the treatment of mild to moderate Alzheimer's disease
    Ramaswamy, K
    Amatniek, J
    Zhu, Y
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2005, 238 : S298 - S298
  • [10] Economic evaluation of galantamine in the treatment of mild to moderate Alzheimer's disease in the United States
    Migliaccio-Walle, K
    Getsios, D
    Caro, JJ
    Ishak, KJ
    O'Brien, JA
    Papadopoulos, G
    CLINICAL THERAPEUTICS, 2003, 25 (06) : 1806 - 1825
12345